Dr. Maria Anitan’s valuable PV insights enrich WDSC session
Important pharmacovigilance topics were discussed during the World Drug Safety Congress Americas in Boston last week, including valuable insights on data privacy shared by Med Communications’ Maria Anitan, MD. Some key questions she brought up for PV professionals to consider:
- Are our adverse event reports anonymized according to regulatory requirements before being shared or submitted?
- What safeguards are in place to prevent unauthorized access to PV data?
- How do we verify the data privacy practices of third-party vendors handling our PV data?
- Is there a clear protocol for reporting and responding to potential data breaches affecting PV data?
- Are data protection and privacy practices integrated into our PV training and procedures?
Contact us for more pharmacovigilance insights. We’re always here to help. 877.477.0977; info@medcomminc.com
